CIK 0001596812 · Non-accelerated filer
Enlivex Ltd.
Sign in to watch- Ticker
- ENLV
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- other
- Phone
- 972 (0) 3 7326616
- Business address
- 37 DEREH MENACHEM BEGIN ST., 15TH FLOOR, TEL AVIV, Israel
- Former names
- Enlivex Therapeutics Ltd., Bioblast Pharma Ltd., BIO BLAST PHARMA LTD.
- 20-F/A Report Annual and Transition Report of Foreign Private Issuers
- UPLOAD Other SEC-generated Letter
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- F-3 Offering F-3
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
Page 14 of 21 · 419 filings